Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Asma Melaine"'
Autor:
Valentine Brousse, Francoise Bernaudin, Asma Melaine, Melanie Goguillot, Meghan Gallagher, Steve Benard, Anoosha Habibi
Publikováno v:
Haematologica, Vol 108, Iss 9 (2023)
The burden of sickle cell disease (SCD) in France has been difficult to apprehend due to the paucity of reliable nationwide epidemiological data. We aimed to describe the epidemiology of SCD and evaluate its burden and costs. Patients with SCD and mo
Externí odkaz:
https://doaj.org/article/113392759619433089bad535245f0da1
Autor:
Jean-François Korobelnik, Cécile Delcourt, Jules Chassetuillier, Catherine Creuzot-Garcher, Asma Melaine, Anne Lejeune, S Bénard, Laure Dupont-Benjamin
Publikováno v:
Journal of Medical Economics
Journal of Medical Economics, Taylor & Francis, 2021, 24 (1), pp.1087-1097. ⟨10.1080/13696998.2021.1971416⟩
Journal of Medical Economics, 2021, 24 (1), pp.1087-1097. ⟨10.1080/13696998.2021.1971416⟩
Journal of Medical Economics, Taylor & Francis, 2021, 24 (1), pp.1087-1097. ⟨10.1080/13696998.2021.1971416⟩
Journal of Medical Economics, 2021, 24 (1), pp.1087-1097. ⟨10.1080/13696998.2021.1971416⟩
International audience; Aims: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy is standard care for neovascular age-related macular degeneration (nAMD), but the recommended monthly injection regimen is burdensome. Evidence sug
Autor:
Bruno Fautrel, Jean-François Bergmann, Cécile Gaujoux-Viala, Stève Bénard, Mélanie Goguillot, Asma Mélaine, Marie Guérin, Alban Edouard
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Objectives The emergence of targeted therapy is changing rheumatoid arthritis (RA) management, but real-world data remain limited. This study aimed to describe real-world RA treatment patterns using data from a French national claims database.Methods
Externí odkaz:
https://doaj.org/article/634e81efc39d4c0cae8dfd381bdcfe6e